International: Deal Digest: Hong Kong and Japan See Year-End Growth Momentum, With PRC Firms Tapping US and European Capital Markets For Growth

January 12, 2023

Shanghai-based medical device company Cryofocus Medtech, which focuses on minimally invasive interventional cryotherapy, recently announced its US$27 million initial public offering in Hong Kong. An O’Melveny team led by corporate partners Ke Zhu, Ke Geng, and Ye Sun advised Cryofocus on both US and Hong Kong laws. International subscribers can read the full article here.